Alle Storys
Folgen
Keine Story von ProMetic Life Sciences mehr verpassen.

ProMetic Life Sciences

ProMetic to Host Conference Call and Live Webcast to Discuss its Second Quarter 2004 Financial Results and Business Highlights

Montreal (ots/PRNewswire)

ProMetic Life Sciences Inc. (TSX: PLI) announced today that the
Company  will host a conference call and live webcast on Wednesday,
August 4, 2004  at 11:00 a.m. (EST) to discuss financial results and
business highlights  for the second quarter ended June 30, 2004. To
access the conference, dial  toll-free +1-800-814-4857 (Canada and
USA) or +1-416-640-4127(International). Please specify to the
operator that you would like to join the "ProMetic  Second Quarter
Financial Results Conference Call." The conference call will  be
webcast live on ProMetic's website at http://www.prometic.com .
Please  connect to ProMetic's website several minutes prior to the
start of the  conference call to ensure adequate time for any
software download that may  be necessary.
About ProMetic Life Sciences
ProMetic Life Sciences Inc. is a biopharmaceutical company
specialised  in the research, development, manufacture and marketing
of a variety of  commercial applications from its proprietary
platform technologies, which  are used in the development of
therapeutics, large-scale purification of  biologics and the
elimination of pathogens/viruses. Headquartered in  Montreal
(Canada), ProMetic has additional facilities in the UK and the USA.
www.prometic.com
This press release contains forward-looking statements that
involve  risks and uncertainties, including, but not limited to the
Company's  ability to develop, manufacture, and successfully
commercialise value-added  pharmaceutical products and to obtain
contracts for its products and  services and commercial acceptance of
advanced affinity separation  technology. Shareholders are cautioned
that these statements are  predictions and these actual events or
results may differ materially from  those anticipated in these
forward-looking statements.

Contact:

For further information: ProMetic Life Sciences Inc.: Analysts &
Investor inquiries: Nicole Blanchard, Managing Partner, Sun
International Communications, +1(450)-627-6600,
Nicole.blanchard@isuncomm.com; Renmark Financial Communications Inc.:
Investor Relations - Brokers: John Boidman, +1(514)-939-3989,
jboidman@renmarkfinancial.com; www.renmarkfinancial.com